[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doctor-en-fu-shen":3,"doctor-lang-ok-en-fu-shen":91},{"id":4,"slug":5,"name":6,"credentials":7,"titles":8,"specialtyName":12,"hospitalName":13,"spokenLanguages":14,"avatarSource":17,"detailHeroSource":18,"clinicalTags":19,"clinicalFocus":37,"expertise":38,"currentPosition":39,"department":12,"academicRole":40,"academicRoleDesc":41,"credentialsList":42,"educations":45,"publications":60,"locations":82,"seoTitle":89,"seoDescription":90},4,"fu-shen","Fu Shen","PhD in Radiation Oncology",[9,10,11],"Chief Physician","Professor","Doctoral Supervisor","Radiation Oncology","Guangzhou Taihe Cancer Hospital",[15,16],"English","Mandarin","https:\u002F\u002Fatt.lumalinkglobal.com\u002Fcarepath\u002Fdoctor\u002Fb0c547f1-d360-4adb-a731-f0858aac8dcd.png","https:\u002F\u002Fatt.lumalinkglobal.com\u002Fcarepath\u002Fdoctor\u002Fbf8942fd-9050-42ab-90d8-1657abe8c308.png",{"conditions":20,"procedures":31},[21,22,23,24,24,25,26,27,28,29,30],"Medulloblastoma","Neuroblastoma","Pediatric Sarcomas","Head and Neck Tumors","Thoracic Tumors","Abdominal Tumors","Gastrointestinal Tumors","Prostate Cancer","Chordoma","Chondrosarcoma",[32,33,34,35,36],"Proton Therapy","Carbon-Ion Radiotherapy","Proton and Heavy-Ion Therapy","Precision Radiotherapy","Particle Therapy Treatment Planning",[21,22,32],"\u003Cp>Professor Shen Fu specializes in proton and heavy-ion radiotherapy and precision radiation treatment for complex solid tumors. His clinical focus includes pediatric tumors, head-and-neck cancers, thoracic malignancies and abdominal or gastrointestinal tumors where highly conformal radiation may help protect nearby critical organs. International training and clinical experience at Johns Hopkins and Fox Chase Cancer Center broadened his approach to multidisciplinary radiation oncology. Through national research leadership and particle-therapy program development, he has contributed to the clinical translation, treatment planning and quality control of advanced radiotherapy technologies.\u003C\u002Fp>","Vice President","Chief Scientist, National Key R&D Program Project on Proton and Heavy-Ion Therapy","Clinical translation of proton and heavy-ion radiotherapy for solid tumors",[43,44],"Vice Chair, Society of Ion Therapy, China Association of Medical Equipment","Vice Chair, Society of Tumor Microenvironment, China Anti-Cancer Association",[46,51,56],{"year":47,"title":48,"institution":49,"description":50},2004,"Research Scientist","Fox Chase Cancer Center","Served as a research scientist at Fox Chase Cancer Center, USA, focusing on clinical radiotherapy and radiation biology research.",{"year":52,"title":53,"institution":54,"description":55},1999,"Postdoctoral Training","Johns Hopkins University School of Medicine Oncology Center","Completed postdoctoral training at the Oncology Center of Johns Hopkins University School of Medicine in 1999.",{"year":57,"title":7,"institution":58,"description":59},1993,"Fudan University Shanghai Cancer Center","Earned a PhD in Radiation Oncology from Fudan University Shanghai Cancer Center in 1993.",[61,65,68,72,75,79],{"title":62,"journal":63,"year":64},"Carbon Ion Radiotherapy for Patients with Extracranial Chordoma or Chondrosarcoma—Initial Experience from Shanghai Proton and Heavy Ion Center","Journal of Cancer",2019,{"title":66,"journal":67,"year":64},"Imaging-Based Individualized Response Prediction of Carbon Ion Radiotherapy for Prostate Cancer Patients","Cancer Management and Research",{"title":69,"journal":70,"year":71},"The predictive role of ADC values in prostate cancer patients treated with carbon-ion radiotherapy","Journal of Cancer Research and Clinical Oncology",2016,{"title":73,"journal":74,"year":71},"Peripheral lymphocyte subset variation predicts prostate cancer carbon ion radiotherapy outcomes","Oncotarget",{"title":76,"journal":77,"year":78},"Charged particle therapy versus photon therapy for patients with hepatocellular carcinoma: a systematic review and meta-analysis","Radiotherapy and Oncology",2015,{"title":80,"journal":81,"year":78},"Photo-thermal effect enhances the efficiency of radiotherapy using Arg-Gly-Asp peptides-conjugated gold nanorods that target αvβ3 in melanoma cancer cells","Journal of Nanobiotechnology",[83],{"institution":84,"address":85,"latitude":86,"longitude":87,"isPrimary":88},"Guangzhou Concord Cancer Center","No. 9 Ciji Road, Sino-Singapore Guangzhou Knowledge City, Huangpu District, Guangzhou, Guangdong Province, China","23.1813899","113.48067",true,"Fu Shen PhD Radiation Oncology","Professor Fu Shen specializes in proton and heavy-ion radiotherapy for complex tumors. Expert in pediatric, head-and-neck, thoracic, and gastrointestinal cancers.",{"en":88}]